FDA gives full approval to Amgen blood cancer drug

(Reuters) - The U.S. Food and Drug Administration said on Thursday it has approved Amgen Inc's cancer drug Kyprolis in combination with certain other therapies to treat patients with multiple myeloma.

http://ift.tt/xePdMM

from Reuters: Health News
via animenewspro